About Mary Rose Reaston
Form D filings for Emerge Diagnostics from 2014 to 2017 list Mary Rose Reaston as executive officer.
Mary Rose Reaston first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Mary Rose Reaston in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mary Rose Reaston works with at each company, as listed on that company's latest Form D.
Emerge Diagnostics, Inc. · Form D, Jun 28, 2017
RT
Robert Thompson
Chief Executive Officer and director
ML
Murray Lappe
Director
WQ
William Quirk
Director
DM
David Miller
Director
PR
Phil Reaston
Executive officer
JW
Jerry Wilkins
Executive officer and director
MC
Michael Connor
Director
MS
Mark Sampson
Director
SW
Scott Wolesson
Director